BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29915224)

  • 1. Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome.
    Krogsgaard LR; Andersen LO'; Johannesen TB; Engsbro AL; Stensvold CR; Nielsen HV; Bytzer P
    Clin Transl Gastroenterol; 2018 Jun; 9(6):161. PubMed ID: 29915224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study.
    Krogsgaard LR; Engsbro AL; Stensvold CR; Nielsen HV; Bytzer P
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):507-513.e2. PubMed ID: 25229421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
    J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.
    Hugerth LW; Andreasson A; Talley NJ; Forsberg AM; Kjellström L; Schmidt PT; Agreus L; Engstrand L
    Gut; 2020 Jun; 69(6):1076-1084. PubMed ID: 31601615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microbiome of the oral mucosa in irritable bowel syndrome.
    Fourie NH; Wang D; Abey SK; Sherwin LB; Joseph PV; Rahim-Williams B; Ferguson EG; Henderson WA
    Gut Microbes; 2016 Jul; 7(4):286-301. PubMed ID: 26963804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
    Zeber-Lubecka N; Kulecka M; Ambrozkiewicz F; Paziewska A; Goryca K; Karczmarski J; Rubel T; Wojtowicz W; Mlynarz P; Marczak L; Tomecki R; Mikula M; Ostrowski J
    Gut Microbes; 2016 Sep; 7(5):397-413. PubMed ID: 27662586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
    Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients.
    Nagel R; Traub RJ; Allcock RJ; Kwan MM; Bielefeldt-Ohmann H
    Microbiome; 2016 Aug; 4(1):47. PubMed ID: 27580855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.
    Liu HN; Wu H; Chen YZ; Chen YJ; Shen XZ; Liu TT
    Dig Liver Dis; 2017 Apr; 49(4):331-337. PubMed ID: 28179092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.
    Heitkemper MM; Cain KC; Shulman RJ; Burr RL; Ko C; Hollister EB; Callen N; Zia J; Han CJ; Jarrett ME
    Benef Microbes; 2018 Apr; 9(3):345-355. PubMed ID: 29633639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects.
    Nourrisson C; Scanzi J; Pereira B; NkoudMongo C; Wawrzyniak I; Cian A; Viscogliosi E; Livrelli V; Delbac F; Dapoigny M; Poirier P
    PLoS One; 2014; 9(11):e111868. PubMed ID: 25365580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
    Sundin J; Aziz I; Nordlander S; Polster A; Hu YOO; Hugerth LW; Pennhag AAL; Engstrand L; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2020 Jan; 10(1):593. PubMed ID: 31953505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea.
    Mohammadzadeh N; Kalani BS; Bolori S; Azadegan A; Gholami A; Mohammadzadeh R; Masjedian Jazi F
    Acta Microbiol Immunol Hung; 2019 Jun; 66(2):189-202. PubMed ID: 31062602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of Dientamoeba fragilis and Blastocystis spp. in Irritable Bowel Syndrome].
    Mumcuoğlu I; Coşkun FA; Aksu N; Pürnak T; Güngör C
    Turkiye Parazitol Derg; 2013; 37(2):73-7. PubMed ID: 23955902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable bowel syndrome in Egyptian patients: plausible risk factors and association with intestinal protozoa.
    Salem AI; El-Taweel HA; Madkour MA; Abd El-Latif NF; Abd-Elrazeq ES
    Trop Doct; 2019 Jul; 49(3):184-188. PubMed ID: 30885054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.